Login to Your Account



Other News To Note


Thursday, December 8, 2011
• Cubist Pharmaceuticals Inc., of Lexington, Mass., said 36.1 million shares of Exton, Pa.-based Adolor Corp. were initially tendered under Cubist's $415 million offer to acquire the biotech. That figure represents about 75 percent of Adolor's shares, and Cubist commenced a subsequent offering period that is scheduled to expire Dec. 9.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription